Locations:
Search IconSearch

Cancer

23-CNR-42100966-CQD-Hero2-650×450 Dr Miller ASTRO article
October 5, 2023/Cancer/Research

Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma is Cost-Effective in Southern China

Use of MRI adds to cost but remains cost-effective due to higher sensitivity

23-CNR-4210967-CQD-Hero-Astro
October 4, 2023/Cancer/Research

Phase 1 Study Supports Dose-Escalating Preoperative SRS for Large Brain Metastases

This approach led to local control for patients with brain metastases more than 2 cm in diameter

23-CNR-4198910-CQD-Hero-650×450 smoldering MM article
September 29, 2023/Cancer/Research

Watch and Wait Still a Viable Option for Many Patients with Smoldering Myeloma

Strategies and risk models are evolving for this asymptomatic condition

23-CNR-4162208-CQD-Hero-650×450 Dr Valente
September 27, 2023/Cancer/Research

Risk of Local Recurrence of DCIS After Mastectomy Appears Unrelated to Margins

Retrospective study involves 18 years of follow-up and shows low risk of local recurrence.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-NEU-4229690-CQD-Podcast-Hero-650×450

Investigating Mitochondria Transfer in Glioblastoma (Podcast)

New research focuses on tumorigenic aspects of communication among brain cells

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight

Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

Laura Shoemaker DO
September 14, 2023/Bioethics/Best Practices

Honoring Values for Patients With Serious Illness

Palliative care specialists know hard conversations can also be valuable ones

23-CNR-4045267-CQD-Hero-650×450-v2 Dr Jagadeesh
September 12, 2023/Cancer/Research

Pirtobrutinib Shows Promise for Older, Heavily Pretreated Patients with CLL

Large trial shows efficacy and lower incidences of heart issues and bleeding events with novel non-covalent BTK inhibitor

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight

Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

Seth Rotz, MD
September 6, 2023/Bioethics

Difficult Disclosures in Pediatric Oncology

Variables affect nuances of the conversation

BackPage 15 of 111Next

Advertisement

Ad